EUCTR2005-006005-61-SI进行中（未招募）不适用
A COMPARISON OF THE EFFICACY AND SAFETY OF THE DORZOLAMIDE/TIMOLOL FIXED COMBINATION GIVEN TWICE DAILY VERSUS THE LATANOPROST/TIMOLOL FIXED COMBINATION GIVEN ONCE EVERY MORNING FOLLOWING A RUN-IN PERIOD WITH TIMOLOL GIVEN ONCE DAILY - Cosopt versus Xalacom
Pharmaceutical Research Network, LLC0 个研究点目标入组 33 人开始时间: 2006年3月8日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- adults with primary open-angle, pseudoexfoliation, or pigment dispersion glaucoma, or ocular hypertension
- •in both eyes
- •- at baseline the intraocular pressure should be 20 to 32 mm Hg inclusive at 08:00
- •measurement (Visit 2) after dosing with timolol the evening before
- •- the intraocular pressure should be 32 mm Hg or less at all time points in both eyes at
- •- visual acuity should be 6/60 or better in the study eye(s)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- any anticipated change in systemic hypotensive therapy during the trial
- •- use of any corticosteroids by any route for more than two weeks during the study
- •- contraindications to study medications
研究者
相似试验
已完成
4 期
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel SyndromeCTRI/2017/11/010529Walter Bushnell Pvt Ltd200
招募中
不适用
Comparison of the the Efficacy and Safety of durable polymer Novolimus-eluting Elixir DESyne X2™ Stent with Bioresorbable Polymer Sirolimus-Eluting Orsiro™ Stent in a Real World” patient populatioKCT0005690Koera University Guro Hospital1,176
进行中（未招募）
不适用
Comparison of efficacy and safety of different regimens of sublingual immunotherapy for Ragweed.EUCTR2011-001682-41-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)45
招募中
不适用
Bortezomib generic versus originalMultiple myeloma requiring treatment patients who were treated with bortezomib based regimen.multiple myeloma, bortezomib, generic bortezomib, original bortezomibTCTR20210927006/A100
进行中（未招募）
1 期
Evaluación de la seguridad y la eficacia de Dotarem en resonancia magnética (RM) en pacientes con lesiones del sistema nervioso central (SNC)SAFETY AND EFFICACY EVALUATION OF DOTAREM® IN MAGNETIC RESONANCE IMAGING (MRI) IN PATIENTS WITH CENTRAL NERVOUS SYSTEM (CNS) LESIONS - SENTIOPacientes con lesiones del sistema nervioso centralMedDRA version: 12.1Level: SOCClassification code 10029205Term: Nervous system disordersEUCTR2010-020319-34-ESGUERBET396